Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
27.15
+0.04 (0.15%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Alkermes Market Cap

Alkermes has a market cap or net worth of $4.48 billion as of April 24, 2025. Its market cap has increased by 3.30% in one year.

Market Cap
4.48B
Enterprise Value
3.80B
1-Year Change
3.30%
Ranking
Category
Stock Price
$27.15

Market Cap Chart

Since December 1, 1998, Alkermes's market cap has increased from $383.70M to $4.48B, an increase of 1,066.35%. That is a compound annual growth rate of 9.75%.

History

DateMarket Cap% Change
Apr 23, 20254.42B-5.12%
Dec 31, 20244.65B0.52%
Dec 29, 20234.63B7.82%
Dec 30, 20224.29B14.15%
Dec 31, 20213.76B18.47%
Dec 31, 20203.18B-1.20%
Dec 31, 20193.21B-29.92%
Dec 31, 20184.59B-45.52%
Dec 29, 20178.42B-0.36%
Dec 30, 20168.45B-29.09%
Dec 31, 201511.91B39.10%
Dec 31, 20148.56B53.99%
Dec 31, 20135.56B127.59%
Dec 31, 20122.44B8.61%
Dec 30, 20112.25B91.59%
Dec 31, 20101.17B31.68%
Dec 31, 2009891.70M-12.16%
Dec 31, 20081.02B-36.29%
Dec 31, 20071.59B18.17%
Dec 29, 20061.35B-22.92%
Dec 30, 20051.75B37.76%
Dec 31, 20041.27B5.23%
Dec 31, 20031.21B197.29%
Dec 31, 2002405.90M-76.06%
Dec 31, 20011.70B-2.38%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 744.65B
UnitedHealth Group 389.54B
Johnson & Johnson 374.10B
AbbVie 313.02B
Novo Nordisk 276.62B
Abbott Laboratories 225.15B
AstraZeneca 213.42B
Novartis AG 208.99B
Market Cap Rankings